Pfizer, Roche Embrace the Microbiome, Leading $43M Bet on Second Genome

Scientists are super-excited about the way cheap, fast DNA sequencing technology is making it possible to gather vivid, detailed information about the microbiome. These are the trillions of bugs in our guts, and on our skin, that humans have co-existed with since the beginning.